clinical and safety performance metrics (april 2021)
TRANSCRIPT
![Page 1: Clinical and Safety Performance Metrics (April 2021)](https://reader031.vdocuments.us/reader031/viewer/2022012014/61599464cddab707ef01822f/html5/thumbnails/1.jpg)
CLINICAL AND SAFETY PERFORMANCE METRICSExecutive Dashboard
NIH Clinical CenterApril 2021
![Page 2: Clinical and Safety Performance Metrics (April 2021)](https://reader031.vdocuments.us/reader031/viewer/2022012014/61599464cddab707ef01822f/html5/thumbnails/2.jpg)
Patients’ Perceptions• Overall Hospital Rating• Would you Recommend the NIH CC?
![Page 3: Clinical and Safety Performance Metrics (April 2021)](https://reader031.vdocuments.us/reader031/viewer/2022012014/61599464cddab707ef01822f/html5/thumbnails/3.jpg)
50
55
60
65
70
75
80
85
90
95
100
Q4 CY 2019 Q1 CY 2020 Q2 CY 2020 Q3 CY 2020 Q4 CY 2020
Perc
ent P
ositi
ve R
espo
nse
Overall Hospital Rating
Overall Rating of NIH CC - Inpatient Overall Rating of NIH CC - Outpatient
CMS HCAHPS Benchmark (Average) NRC Benchmark (Average)
![Page 4: Clinical and Safety Performance Metrics (April 2021)](https://reader031.vdocuments.us/reader031/viewer/2022012014/61599464cddab707ef01822f/html5/thumbnails/4.jpg)
50
55
60
65
70
75
80
85
90
95
100
Q4 CY 2019 Q1 CY 2020 Q2 CY 2020 Q3 CY 2020 Q4 CY 2020
Perc
ent P
ositi
ve R
espo
nse
Would You Recommend the NIH CC?
Would Recommend NIH CC - Inpatient Would Recommend NIH CC - Outpatient
CMS HCAHPS Benchmark (Average) NRC Benchmark (Average)
![Page 5: Clinical and Safety Performance Metrics (April 2021)](https://reader031.vdocuments.us/reader031/viewer/2022012014/61599464cddab707ef01822f/html5/thumbnails/5.jpg)
Infection Control Metrics • Hand Hygiene• Central-Line Associated Bloodstream Infections
• Whole-house• Intensive Care Unit
• Catheter Associated Urinary Tract Infections• Intensive Care Unit• Surgical Oncology
![Page 6: Clinical and Safety Performance Metrics (April 2021)](https://reader031.vdocuments.us/reader031/viewer/2022012014/61599464cddab707ef01822f/html5/thumbnails/6.jpg)
82%
84%
86%
88%
90%
92%
94%
96%
98%
100%
2019-Q4 2020-Q1 2020-Q2 2020-Q3 2020-Q4
Perc
ent A
dher
ence
Hand Hygiene Compliance
![Page 7: Clinical and Safety Performance Metrics (April 2021)](https://reader031.vdocuments.us/reader031/viewer/2022012014/61599464cddab707ef01822f/html5/thumbnails/7.jpg)
0.00
0.20
0.40
0.60
0.80
1.00
1.20
1.40
2019-Q4 2020-Q1 2020-Q2 2020-Q3 2020-Q4
Infe
ctio
ns p
er 1
,000
cat
hete
r day
sWholehouse Central-Line Associated Bloodstream Infection (CLABSI) Rate
![Page 8: Clinical and Safety Performance Metrics (April 2021)](https://reader031.vdocuments.us/reader031/viewer/2022012014/61599464cddab707ef01822f/html5/thumbnails/8.jpg)
0.00
0.50
1.00
1.50
2.00
2.50
3.00
2019-Q4 2020-Q1 2020-Q2 2020-Q3 2020-Q4
Infe
ctio
nspe
r 1,0
00 c
athe
ter d
ays
ICU Central-Line Associated Bloodstream Infection (CLABSI) Rate
ICU CLABSI Rate NHSN ICU Benchmark2013 CDC National Healthcare Safety Network (NHSN) Benchmark: Critical Care Units, Medical/Surgical -major teaching mean 1.1
![Page 9: Clinical and Safety Performance Metrics (April 2021)](https://reader031.vdocuments.us/reader031/viewer/2022012014/61599464cddab707ef01822f/html5/thumbnails/9.jpg)
0.00
0.50
1.00
1.50
2.00
2.50
3.00
3.50
4.00
4.50
5.00
2019-Q4 2020-Q1 2020-Q2 2020-Q3 2020-Q4
Infe
ctio
ns p
er 1
,000
fole
y da
ys
ICU Catheter-Associated Urinary Tract Infections (CAUTI) Rate
ICU CAUTI Rate NHSN ICU Benchmark2013 CDC National Healthcare Safety Network (NHSN) Benchmark: Critical Care Units, Medical/Surgical -major teaching mean 2.7
![Page 10: Clinical and Safety Performance Metrics (April 2021)](https://reader031.vdocuments.us/reader031/viewer/2022012014/61599464cddab707ef01822f/html5/thumbnails/10.jpg)
0.00
1.00
2.00
3.00
4.00
5.00
6.00
7.00
8.00
9.00
10.00
2019-Q4 2020-Q1 2020-Q2 2020-Q3 2020-Q4
Infe
ctio
ns p
er 1
,000
fole
y da
ysSurgical Oncology Catheter-Associated Urinary Tract Infections
(CAUTI) Rate
Surgical Oncology CAUTI Rate NHSN Medical/Surgical Benchmark2013 CDC National Healthcare Safety Network (NHSN) Benchmark: Inpatient Wards, Medical/Surgical mean 1.3
![Page 11: Clinical and Safety Performance Metrics (April 2021)](https://reader031.vdocuments.us/reader031/viewer/2022012014/61599464cddab707ef01822f/html5/thumbnails/11.jpg)
0.00
0.50
1.00
1.50
2.00
2.50
3.00
3.50
4.00
4.50
2019-Q4 2020-Q1 2020-Q2 2020-Q3 2020-Q4
Infe
ctio
ns p
er 1
00 p
roce
dure
s
Surgical Site Infections (SSI) Rate
SSI Rate 2018 Clinical Center Average
![Page 12: Clinical and Safety Performance Metrics (April 2021)](https://reader031.vdocuments.us/reader031/viewer/2022012014/61599464cddab707ef01822f/html5/thumbnails/12.jpg)
Nursing Quality Metrics • Falls• Pressure Injury• Medication Administration Barcoding
![Page 13: Clinical and Safety Performance Metrics (April 2021)](https://reader031.vdocuments.us/reader031/viewer/2022012014/61599464cddab707ef01822f/html5/thumbnails/13.jpg)
0.00
0.50
1.00
1.50
2.00
2.50
3.00
Q3 CY 2019 Q4 CY 2019 Q1 CY 2020 Q2 CY 2020 Q3 CY 2020 Q4 CY 2020
Falls
per
1,0
00 p
atie
nt d
ays
Inpatient Falls Rate
Quarterly Rate NDNQI Benchmark Inpatient Falls with Injury
![Page 14: Clinical and Safety Performance Metrics (April 2021)](https://reader031.vdocuments.us/reader031/viewer/2022012014/61599464cddab707ef01822f/html5/thumbnails/14.jpg)
0
1
2
3
4
5
6
7
Q4 CY 2019 Q1 CY 2020 Q2 CY 2020 Q3 CY 2020 Q4 CY 2020
% o
f sur
veye
d pa
tient
s w
ith p
ress
ure
inju
ry
Pressure Injury Prevalence
Quarterly RateNDNQI Benchmark for Total Pressure Injury Rate only
![Page 15: Clinical and Safety Performance Metrics (April 2021)](https://reader031.vdocuments.us/reader031/viewer/2022012014/61599464cddab707ef01822f/html5/thumbnails/15.jpg)
90%
91%
92%
93%
94%
95%
96%
97%
98%
99%
100%
Q4 CY 2019 Q1 CY 2020 Q2 CY 2020 Q3 CY 2020 Q4 CY 2020
% B
arco
de U
se
Medication Administration Barcode Use
Clinical Center Rate Goal
![Page 16: Clinical and Safety Performance Metrics (April 2021)](https://reader031.vdocuments.us/reader031/viewer/2022012014/61599464cddab707ef01822f/html5/thumbnails/16.jpg)
Emergency Response• Code Blue and Rapid Response
• Types of Patients• Type of Event• Patient Disposition
![Page 17: Clinical and Safety Performance Metrics (April 2021)](https://reader031.vdocuments.us/reader031/viewer/2022012014/61599464cddab707ef01822f/html5/thumbnails/17.jpg)
Q1 CY 2020 Q2 CY 2020 Q3 CY 2020 Q4 CY 2020 TotalInpt 23 6 20 23 72Outpt 20 1 6 12 39Employee 12 4 10 10 36Visitor 4 2 1 2 9Incorrect Calls 0 0 0 0 0
0
20
40
60
80
100
120
140
160
180N
umbe
r
Code Blue Response: Types of "Patients"
![Page 18: Clinical and Safety Performance Metrics (April 2021)](https://reader031.vdocuments.us/reader031/viewer/2022012014/61599464cddab707ef01822f/html5/thumbnails/18.jpg)
Q1 CY 2020 Q2 CY 2020 Q3 CY 2020 Q4 CY 2020 TOTALBrain Code 3 0 0 2 5Arrest 5 0 6 3 14Acute Emergency 15 9 21 24 69Stable Event 36 4 9 18 67
0
20
40
60
80
100
120
140
160
180N
umbe
r
Code Blue Response: Type of Event
![Page 19: Clinical and Safety Performance Metrics (April 2021)](https://reader031.vdocuments.us/reader031/viewer/2022012014/61599464cddab707ef01822f/html5/thumbnails/19.jpg)
Q1 CY 2020 Q2 CY 2020 Q3 CY 2020 Q4 CY 2020 TOTALTransfer to ICU 12 4 15 13 44Transfer to OSH 13 4 9 14 40Remained on Unit 22 4 10 11 47Expired 0 0 1 1 2Released 3 1 0 0 4Other 9 0 1 8 18
0
20
40
60
80
100
120
140
160
180N
umbe
r
Code Blue Response: Patient Disposition
![Page 20: Clinical and Safety Performance Metrics (April 2021)](https://reader031.vdocuments.us/reader031/viewer/2022012014/61599464cddab707ef01822f/html5/thumbnails/20.jpg)
Q1 CY 2020 Q2 CY 2020 Q3 CY 2020 Q4 CY 2020 TotalICU 8 2 5 4 19Unit/Other 2 0 6 1 9Remained on Unit 15 3 5 17 40
0
10
20
30
40
50
60
70
80N
umbe
r
Rapid Response Team: Patient Disposition
![Page 21: Clinical and Safety Performance Metrics (April 2021)](https://reader031.vdocuments.us/reader031/viewer/2022012014/61599464cddab707ef01822f/html5/thumbnails/21.jpg)
Blood and Blood Product Use• Crossmatch to Transfusion (C:T) Ratio• Transfusion Reaction by Class• Unacceptable Blood Bank Specimens
![Page 22: Clinical and Safety Performance Metrics (April 2021)](https://reader031.vdocuments.us/reader031/viewer/2022012014/61599464cddab707ef01822f/html5/thumbnails/22.jpg)
0.00
0.50
1.00
1.50
2.00
2.50
Q4 CY 2019 Q1 CY 2020 Q2 CY 2020 Q3 CY 2020 Q4 CY 2020
Cros
smat
ch to
Tra
nsfu
sed
Uni
ts R
atio
Crossmatch to Transfusion (C/T) Ratio(The NIH CC goal is to have a C:T ratio of 2.0 or less. Monitoring this metric ensures that blood is not held unused in reserve when it
could be available for another patient.)
C/T Ratio CC C/T Ratio Goal
![Page 23: Clinical and Safety Performance Metrics (April 2021)](https://reader031.vdocuments.us/reader031/viewer/2022012014/61599464cddab707ef01822f/html5/thumbnails/23.jpg)
0.00%
0.20%
0.40%
0.60%
0.80%
1.00%
1.20%
1.40%
Q4 CY 2019 Q1 CY 2020 Q2 CY 2020 Q3 CY 2020 Q4 CY 2020
Perc
ent o
f Tra
nsfu
sion
s
Transfusion Reactions by Class
Anaphylactic Other Febrile, Nonhemolytic Hemolytic, Septic, Anaphylactoid, and TRALI
![Page 24: Clinical and Safety Performance Metrics (April 2021)](https://reader031.vdocuments.us/reader031/viewer/2022012014/61599464cddab707ef01822f/html5/thumbnails/24.jpg)
0.0%
0.5%
1.0%
1.5%
2.0%
2.5%
3.0%
3.5%
Q4 CY 2019 Q1 CY 2020 Q2 CY 2020 Q3 CY 2020 Q4 CY 2020
Perc
ent U
nacc
epta
ble
Spec
imen
sUnacceptable Blood Bank Specimens
% Specimens with Collection Problems CC Threshold
![Page 25: Clinical and Safety Performance Metrics (April 2021)](https://reader031.vdocuments.us/reader031/viewer/2022012014/61599464cddab707ef01822f/html5/thumbnails/25.jpg)
Clinical Documentation• Medical Record Completeness
• Delinquent Records• “Agent for” Countersignature Adherence• Unacceptable Abbreviation Use
• Accuracy of Coding
![Page 26: Clinical and Safety Performance Metrics (April 2021)](https://reader031.vdocuments.us/reader031/viewer/2022012014/61599464cddab707ef01822f/html5/thumbnails/26.jpg)
0.0%
10.0%
20.0%
30.0%
40.0%
50.0%
60.0%
Q4 CY 2019 Q1 CY 2020 Q2 CY 2020 Q3 CY 2020 Q4 CY 2020
% re
cord
s de
linqu
ent a
fter
30
days
Delinquent Records(>30 days post discharge)
% Records Delinquent Joint Commission Benchmark
![Page 27: Clinical and Safety Performance Metrics (April 2021)](https://reader031.vdocuments.us/reader031/viewer/2022012014/61599464cddab707ef01822f/html5/thumbnails/27.jpg)
50%
55%
60%
65%
70%
75%
80%
85%
90%
95%
100%
Q4 CY 2019 Q1 CY 2020 Q2 CY 2020 Q3 CY 2020 Q4 CY 2020
% v
erba
l ord
ers s
igne
d in
72
hour
s
"Agent for" Orders Countersignature Compliance
% of Compliance CC Goal
![Page 28: Clinical and Safety Performance Metrics (April 2021)](https://reader031.vdocuments.us/reader031/viewer/2022012014/61599464cddab707ef01822f/html5/thumbnails/28.jpg)
75%
80%
85%
90%
95%
100%
Q3 CY 2019 Q4 CY 2019 Q1 CY 2020 Q2 CY 2020 Q3 CY 2020
% a
ppro
pria
te u
se o
f abb
revi
atio
ns"Do Not Use" Abbreviation Adherence
Compliance with Abbreviation Use CC Goal
![Page 29: Clinical and Safety Performance Metrics (April 2021)](https://reader031.vdocuments.us/reader031/viewer/2022012014/61599464cddab707ef01822f/html5/thumbnails/29.jpg)
0%
10%
20%
30%
40%
50%
60%
70%
80%
90%
100%
Q3 CY 2019 Q4 CY 2019 Q1 CY 2020 Q2 CY 2020 Q3 CY 2020
% a
ccur
acy
of c
odin
g
Accuracy of Record Coding
Accuracy of Coding CC Goal
![Page 30: Clinical and Safety Performance Metrics (April 2021)](https://reader031.vdocuments.us/reader031/viewer/2022012014/61599464cddab707ef01822f/html5/thumbnails/30.jpg)
Employee Safety • Occupational Injury and Illness
![Page 31: Clinical and Safety Performance Metrics (April 2021)](https://reader031.vdocuments.us/reader031/viewer/2022012014/61599464cddab707ef01822f/html5/thumbnails/31.jpg)
0
1
2
3
4
5
6
7
8
2017 2018 2019 2020
Case
Inci
denc
e Ra
teOccupational Injuries and Illnesses for CC Employees
TRC ORC DAFW DJTR DARTTRC: Total Recordable Cases; ORC: Other Recordable Cases; DAFW: Days Away From Work; DJTR: Days Job Transfer, Restriction; DART: Days Away, Restricted or Transferred (DAFW + DJTR)